Background: Several studies assayed the pharmacokinetics of tilmicosin in broilers at a dosage of (25mg/kg.b.wt.). The aim of this study was to investigate the pharmacokinetics and tissue residues of tilmicosin following single and repeated oral administrations (25mg/kg.b.wt.) once daily for 5 consecutive days in healthy and experimentally Mycoplasma gallisepticum and E. coli infected broilers.Methods: After oral administrations of tilmicosin (25 mg/kg.b.wt.) one ml blood was collected from the right wing vein and tissues samples for determination of tilmicosin concentrations and the disposition kinetics of it by the microbiological assay method using Bacillus subtilis (ATCC 6633) as a test organism.Results: In this study, the plasma concentration time graph was characteristic of a two-compartments open model. Following a single oral administration, tilmicosin was rapidly absorbed in both healthy and experimentally infected broilers with an absorption half-life of (t0.5(ab)) 0.45 and 0.52h, maximum serum concentration (Cmax) was 1.06 and 0.69μg/ml at (tmax) about 2.56 and 2.81h, (t0.5(el)) was 21.86 and 22.91h and (MRT) was 32.15 and 33.71h, respectively; indicating the slow elimination of tilmicosin in chickens. The in-vitro protein binding was 9.72±0.83%. Serum concentrations of tilmicosin following repeated oral administration once daily for five consecutive days, almost peaked 2h after each dose with lower significant values recorded in experimentally infected broiler chickens than in healthy ones.Conclusions: This study showed that tilmicosin was cleared rapidly from tissues. The highest residue values were recorded in the lung followed by liver and kidneys while the lowest values were recorded in spleen, fat and thigh muscles. Five days for withdrawal period of tilmicosin suggested in broilers.

No abstract

No abstract

The pharmacokinetics of marbofloxacin was studied following a single intravenous, oral administration in normal broiler chickens and repeated oral administrations in normal and experimentally E.coli infected broiler chickens. The pharmacokinetic parameters following a single intravenous injection of 2 mg/kg b.wt., revealed that marbofloxacin obeyed a two compartments open model, distribution half-life (t 0.5(α) ) was 0.25±0.02 h, volume of distribution (V dss ) was 0.76±0.08 L/kg, elimination half-life (t 0 . 5(β) ) was 5.43±0.87 h and total body clearance (CL tot ) was 0.09±0.002 l/kg/h. Following a single oral administration, marbofloxacin was rapidly and efficiently absorbed through gastrointestinal tract of chickens as the absorption half-life (t 0.5 (ab) : 0.62±0.02 h). Maximum serum concentration (C max ) was 1.15±0.01 μg/ml, reached its maximum time (t max ) at 2.53±0.04 h, elimination half-life (t 0.5 (el) ) was 7.36±0.20 h indicating the tendency of chickens to eliminate marbofloxacin in slow rate. Oral bioavailability was 73.57± 1.90 % indicating good absorption of marbofloxacin after oral administration. Serum concentrations of marbofloxacin following repeated oral administration of 2 mg/kg b.wt. once daily for five consecutive days, peaked 2 hours after each oral dose with lower significant values recorded in experimentally infected broiler chickens than in normal ones. Tissues residues of marbofloxacin in slaughtered normal chickens was highly in those tissues lung, liver, and kidneys in chickens and the chicken must not be slaughtered before 3 days of stopping of drug administration. It was concluded that the in-vitro protein binding was 12.33±0.82%.

The active profile of cefquinome in goats was concentrated after single intravenous organization of cefquinome alone and single intravenous organizations in goats pretreated with meloxicam at a portion of 2 mg/kg b.wt. Serum groupings of cefquinome were dictated by utilizing superior fluid chromatography (HPLC). Following compartmental examination, a two-compartment open model best portrayed the fixation time information of cefquinome after i.v. organization The outcomes uncovered that after a solitary intravenous injection, cefquinome was distinguished till 24 hours, dispersion half-life (t1/2á) of cefquinome was 0.281 ± 0.055 h, elimination half-life (t1/2â) was of 5.46 ± 0.22 h and clearance (CL) was 0.04 ± 0.0013 (L/kg/h), volume of distribution at steady state (Vdss) was 0.31 ± 0.018 (L/kg). Following a single intravenous injection pretreated with meloxicam, distribution half-life (t1/2á) was 0.227 ± 0.07 h, elimination half-life (t1/2â) was of 3.63 ± 0.055 h and clearance (CL) was 0.056 ± 0.0022 (L/kg/h), volume of distribution at steady state (Vdss) was 0.296 ± 0.0163 (L/kg). From this examination, we inferred that organization of meloxicam (0.2 mg/kg b.wt.) may be successfully coadministrated with cefquinome (2 mg/kg b.wt.) for combating bacterial infections with an inflammatory condition in goats without any antagonistic effect on the kinetics of cefquinome.